The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin
Open Access
- 1 August 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 14 (8) , 1836-1841
- https://doi.org/10.1093/ndt/14.8.1836
Abstract
Both angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers are widely used in renal failure patients in the treatment of hypertension [1], left ventricular dysfunction [2], and diabetic nephropathy [3]. Their efficacy in these conditions is well established, and generally both classes of drugs are well tolerated, with a low incidence of side effects [4]. Thus, ACE inhibitors may induce skin rashes, angioneurotic oedema, diarrhoea, cough, and dizziness [5], while the angiotensin II blockers have a side effect profile not dissimilar to placebo.Keywords
This publication has 21 references indexed in Scilit:
- The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patientsNephrology Dialysis Transplantation, 1999
- Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effectsAmerican Journal of Kidney Diseases, 1997
- Angiotensin Converting Enzyme Inhibitors Are Associated with the Need for Increased Recombinant Human Erythropoietin Maintenance Doses in Hemodialysis PatientsNephron, 1997
- Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients?Nephrology Dialysis Transplantation, 1996
- Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: possible implications of angiotensin-converting enzyme inhibitorsNephrology Dialysis Transplantation, 1996
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Enalapril-Associated Anemia in Renal Transplant Recipients Treated for HypertensionAmerican Journal of Kidney Diseases, 1991
- Safety issues during antihypertensive treatment with angiotensin converting enzyme inhibitorsThe American Journal of Medicine, 1988
- Angiotensin converting enzyme inhibitors. Properties and side effects.Hypertension, 1988
- Worsening of Anemia Induced by Long-Term Use of Captopril in Hemodialysis PatientsAmerican Journal of Nephrology, 1984